The Lancet Haematology
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherELSEVIER SCI LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2014
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 50% |
| 4-6 | 39% |
| 7-9 | 10% |
| >9 | 2% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has The Lancet Haematology been publishing? 
The The Lancet Haematology has been publishing since 2014 till date.
How frequently is the The Lancet Haematology published?
The Lancet Haematology is published Monthly.
Who is the publisher of The Lancet Haematology?
The publisher of The Lancet Haematology is ELSEVIER SCI LTD.
How can I view the journal metrics of The Lancet Haematology on editage?
For the The Lancet Haematology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of The Lancet Haematology?
The eISSN number is 2352-3026 and pISSN number is 2352-3026 for The Lancet Haematology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Risk stratification, Overall survival, Cohort study, Progression-free survival, Antibody response, Rituximab, Diffuse large B-cell lymphoma, Newborn screening, Anticoagulant, Minimal residual disease, Prognostic score, Dexamethasone, Hematopoietic stem cell transplantation, Lenalidomide, Chimeric antigen receptor, Chemoimmunotherapy, Malaria, Immunotherapy, Immune thrombocytopenia, Systematic review.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.